Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jacob Eli Berchuck, M.D.

Concepts (202)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Jacob Berchuck's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Jacob Berchuck has written about over time.
Complement Pathway, Alternative, 2 publications between 2013 and 2014, average publication date October 2013. Retinal Pigment Epithelium, 2 publications between 2013 and 2014, average publication date October 2013. Fat Necrosis, 1 publications between 2015 and 2015, average publication date April 2015. Pericardium, 1 publications between 2015 and 2015, average publication date April 2015. Antineoplastic Agents, Hormonal, 2 publications between 2021 and 2021, average publication date February 2021. Neoplasms, Hormone-Dependent, 1 publications between 2021 and 2021, average publication date February 2021. Neoplastic Cells, Circulating, 1 publications between 2021 and 2021, average publication date February 2021. DNA Damage, 1 publications between 2021 and 2021, average publication date April 2021. DNA Repair, 1 publications between 2021 and 2021, average publication date April 2021. Germ-Line Mutation, 4 publications between 2019 and 2022, average publication date May 2021. Androgen Antagonists, 2 publications between 2021 and 2021, average publication date June 2021. Neuroendocrine Tumors, 2 publications between 2021 and 2022, average publication date September 2021. Prostatic Neoplasms, 11 publications between 2021 and 2023, average publication date December 2021. Receptors, Androgen, 3 publications between 2021 and 2022, average publication date January 2022. Carcinoma, Neuroendocrine, 1 publications between 2022 and 2022, average publication date February 2022. Bile Duct Neoplasms, 1 publications between 2022 and 2022, average publication date September 2022. Biliary Tract Neoplasms, 1 publications between 2022 and 2022, average publication date September 2022. Neoplastic Syndromes, Hereditary, 1 publications between 2024 and 2024, average publication date January 2024.

To see the data from this visualization as text, click here.
Berchuck's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (202)
Explore
_
Co-Authors (100)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.